Alberta Investment Management Corp (AIMCo)’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-12,060
Closed -$221K 1107
2020
Q2
$221K Hold
12,060
﹤0.01% 981
2020
Q1
$188K Hold
12,060
﹤0.01% 873
2019
Q4
$258K Buy
12,060
+7,420
+160% +$153K ﹤0.01% 848
2019
Q3
$87K Hold
4,640
﹤0.01% 882
2019
Q2
$121K Buy
+4,640
New +$105K ﹤0.01% 892

Other funds holding RIGL

Alberta Investment Management Corp (AIMCo)'s RIGL Position: Q3 2020 in Review

Alberta Investment Management Corp (AIMCo) sold out of Rigel Pharmaceuticals (RIGL) in Q3 2020, closing a stake of 12,060 shares — an estimated $221K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in RIGL in Q2 2019 and held it in 5 quarters. The position peaked at $258K in Q4 2019. 138 funds tracked by Wall St. Rank hold RIGL as of Q3 2020.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Rigel Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 12,060 Rigel Pharmaceuticals shares in Q3 2020, an estimated $221K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Rigel Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Rigel Pharmaceuticals position peaked at $258K in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2020.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2020, filed 26 Oct 2020.